Resource Library

Bookmark this page for information about prescribing, training, and more. Procedure resources on this page are intended as a training supplement only for the Eversense CGM System. They are not a substitute for the Eversense CGM Sensor Insertion and Removal Training Program for Certification. Only qualified health care providers who have successfully completed the Eversense Sensor Insertion and Removal Training Program and have read and understood the procedure instructions may perform the insertion and removal procedure on patients.

Procedure

Disclaimer regarding Eversense CGM Insertion & Removal Training Program:

  • Only health care providers (physicians, physician assistants, and/or nurse practitioners) who have successfully completed the Eversense CGM Insertion & Removal Training Program & have read and understood the Eversense CGM Sensor Insertion & Removal Instructions may perform the procedure on patients.
  • Procedure Certification requires​:
    • Pre-training & at least 3 observed insertion procedures by the Eversense Clinical trainer​
    • Pre-training & at least 3 observed removal procedures by the Eversense Clinical trainer​
    • Observed procedures must be on-label, successful, and by the end of training performed without coaching​

Become a Provider

Fill out this brief form to get Eversense updates. Want to reach us directly? Contact us via the contact page.

Thank you.

We have received your message.

A general error occurred. Please try again later.

By clicking ‘submit’ you confirm you are over 18, and agree to Ascensia, or our trusted partner, collecting and using your health-related information to check your insurance coverage and eligibility for Eversense. An Ascensia Diabetes Care representative will be in touch about getting started, usually by phone or text message.

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.

The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.

For important safety information, see bit.ly/eversensesafety

Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

 

PP-SENS-E3-GBL-0068